This is a proposal to establish and characterize an adult canine model for the study of treated and untreated bladder outflow obstruction caused by hormonally induced prostatic hyperplasia. The only mammals in which benign prostatic hyperplasia spontaneously occurs are man and dog. For this reason, the canine prostate has been an excellent model for studying the hormonal basis of prostatic growth and hyperplasia. In man, the leading causes of morbidity from prostatic enlargement are due to bladder outlet obstruction. In the dog, these symptoms have not been produced because the dog lacks a capsule similar to man. Investigators have thus been unable to study the effects of gradual obstruction in a mature or senescent mammalian model. We propose to establish a model of bladder outlet obstruction as close to the human condition as possible. A surgical capsule will be implanted around the canine prostate to provide maximum anatomical similarity of the human situation. The prostate will be subjected to controlled hormonal stimulation to produce gradual growth and obstruction. The effects of obstruction on organ appearance, performance and composition will be evaluated by means of urodynamic, cystoscopic, histological and biochemical study. Finally, the effects of treatment, by removal of the capsule and the obstructing prostate, will be evaluated.

Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
1996
Total Cost
Indirect Cost
Chon, J K; Borkowski, A; Partin, A W et al. (1999) Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161:2002-8
Crone, J K; Burnett, A L; Chamness, S L et al. (1998) Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid, and pathology correlations. J Androl 19:358-64
Jarrard, D F; Paul, R; van Bokhoven, A et al. (1997) P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin Cancer Res 3:2121-8
Barrack, E R (1997) TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31:61-70
Sommerfeld, H J; Meeker, A K; Piatyszek, M A et al. (1996) Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56:218-22
Morton Jr, R A; Watkins, J J; Bova, G S et al. (1996) Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue. J Urol 156:512-6
Epner, D E; Coffey, D S (1996) There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate 28:372-8
McEntee, M F; Epstein, J I; Syring, R et al. (1996) Characterization of prostatic basal cell hyperplasia and neoplasia in aged macaques: comparative pathology in human and nonhuman primates. Prostate 29:51-9
Burnett, A L; Saito, S; Maguire, M P et al. (1995) Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia. J Urol 153:212-7
Chamness, S L; Ricker, D D; Crone, J K et al. (1995) The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101-7

Showing the most recent 10 out of 23 publications